Prevalence and risk of metabolic syndrome in patients with systemic lupus erythematosus: A meta‐analysis

The systematic review and meta-analysis demonstrated the prevalence of MetS in patients with SLE was 26% and the patients with SLE were more prone to having MetS than the control population. The analysis was a basic summary of all relevant researches and provided valuable evidence for prevention and treatment.